Procyon Corporation
Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calci… Read more
Market Cap & Net Worth: Procyon Corporation (PCYN)
Procyon Corporation (PINK:PCYN) has a market capitalization of $1.47 Million ($1.47 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #36614 globally and #11912 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procyon Corporation's stock price $0.18 by its total outstanding shares 8140628 (8.14 Million).
Procyon Corporation Market Cap History: 2015 to 2025
Procyon Corporation's market capitalization history from 2015 to 2025. Data shows growth from $814.06K to $1.47 Million (7.60% CAGR).
Procyon Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Procyon Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.22x
Procyon Corporation's market cap is 0.22 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
43.24x
Procyon Corporation's market cap is 43.24 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.07 Million | $3.45 Million | $109.57K | 0.31x | 9.76x |
| 2017 | $1.47 Million | $4.01 Million | $12.38K | 0.37x | 118.38x |
| 2018 | $2.36 Million | $4.02 Million | -$255.73K | 0.59x | N/A |
| 2019 | $2.20 Million | $4.19 Million | $27.22K | 0.52x | 80.74x |
| 2020 | $6.51 Million | $4.33 Million | $111.66K | 1.50x | 58.33x |
| 2021 | $2.93 Million | $4.72 Million | $694.35K | 0.62x | 4.22x |
| 2022 | $2.28 Million | $4.84 Million | -$209.79K | 0.47x | N/A |
| 2023 | $1.39 Million | $4.69 Million | -$50.24K | 0.30x | N/A |
| 2024 | $1.64 Million | $4.98 Million | -$341.14K | 0.33x | N/A |
| 2025 | $1.47 Million | $6.67 Million | $33.89K | 0.22x | 43.24x |
Competitor Companies of PCYN by Market Capitalization
Companies near Procyon Corporation in the global market cap rankings as of March 19, 2026.
Key companies related to Procyon Corporation by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Procyon Corporation Historical Marketcap From 2015 to 2025
Between 2015 and today, Procyon Corporation's market cap moved from $814.06K to $ 1.47 Million, with a yearly change of 7.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.47 Million | -10.45% |
| 2024 | $1.64 Million | +17.54% |
| 2023 | $1.39 Million | -38.93% |
| 2022 | $2.28 Million | -22.22% |
| 2021 | $2.93 Million | -55.00% |
| 2020 | $6.51 Million | +196.30% |
| 2019 | $2.20 Million | -6.86% |
| 2018 | $2.36 Million | +61.06% |
| 2017 | $1.47 Million | +37.09% |
| 2016 | $1.07 Million | +31.30% |
| 2015 | $814.06K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Procyon Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.47 Million USD |
| MoneyControl | $1.47 Million USD |
| MarketWatch | $1.47 Million USD |
| marketcap.company | $1.47 Million USD |
| Reuters | $1.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.